{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:22:08Z","timestamp":1780093328524,"version":"3.54.0"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Antiretroviral toxic neuropathy (ATN) is associated with dideoxynucleoside reverse transcriptase inhibitor use in patients infected with HIV, possibly as a result of mitochondrial toxicity. Acetyl\u2010<jats:sc>l<\/jats:sc>\u2010carnitine (ALC) has been linked to symptomatic improvement in ATN. We present an open\u2010label single\u2010arm pilot study to evaluate changes in intra\u2010epidermal nerve fibre (IENF) density and mitochondrial DNA (mtDNA) copies\/cell among subjects treated with 3000\u2003mg ALC daily.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Punch skin biopsies were examined at baseline and after 24 weeks of therapy. Participants reported neuropathic symptoms using the Gracely Pain Intensity Score. Neurological examinations were completed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty\u2010one subjects completed the study. ALC was generally well tolerated. The IENF density did not change in cases completing 24 weeks of ALC therapy, with median (90% confidence interval) IENF changes of \u22121.70 (\u22123.50, \u221e) (<jats:italic>P<\/jats:italic>=0.98) and 2.15 (\u22120.10, \u221e) (<jats:italic>P<\/jats:italic>=0.11) for the distal leg and proximal thigh, respectively. Fat mtDNA copies\/cell did not change with therapy. Improvements in neuropathic pain (<jats:italic>P<\/jats:italic>&lt;0.01), paresthesias (<jats:italic>P<\/jats:italic>=0.01), and symptoms of numbness (<jats:italic>P<\/jats:italic>&lt;0.01) were noted. Similarly, improvement was noted on the Gracely Pain Intensity Score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ALC therapy coincided with improvements in subjective measures of pain in this open\u2010label single\u2010arm study. However, changes were not observed in objective measures of IENF density or mtDNA levels, providing little objective support for use of ALC in this setting.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2008.00658.x","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T05:35:22Z","timestamp":1232429722000},"page":"103-110","source":"Crossref","is-referenced-by-count":28,"title":["Acetyl\u2010<scp>l<\/scp>\u2010carnitine and nucleoside reverse transcriptase inhibitor\u2010associated neuropathy in HIV infection"],"prefix":"10.1111","volume":"10","author":[{"given":"V","family":"Valcour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u2010M","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bartt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gerschenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SR","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BA","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GJ","family":"Ebenezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Shikuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JC","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the AIDS Clinical Trials Group (ACTG) 5157protocol team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"325","article-title":"HIV\u2010associated neuropathic pain","volume":"19","author":"Verma S","year":"2005","journal-title":"epidemiology, pathophysiology and management"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520330023005"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6.1678"},{"key":"e_1_2_6_5_2","first-page":"481","article-title":"Peripheral neuropathy with nucleoside antiretrovirals","volume":"19","author":"Moyle GJ","year":"1998","journal-title":"risk factors, incidence and management"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70165-4"},{"key":"e_1_2_6_7_2","first-page":"999","article-title":"Low\u2010dose zalcitabine\u2010related toxic neuropathy","volume":"46","author":"Blum AS","year":"1996","journal-title":"frequency, natural history, and risk factors"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.12.1764"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0026-895X(25)11067-5","article-title":"Effect of anti\u2010human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity","volume":"39","author":"Chen CH","year":"1991","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305020-00024"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00019"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80064-8"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199702000-00008"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111090-00025"},{"key":"e_1_2_6_15_2","first-page":"655","article-title":"Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS","volume":"8","author":"De Simone C","year":"1994","journal-title":"effect of oral l-carnitine"},{"key":"e_1_2_6_16_2","first-page":"1549","article-title":"Acetyl\u2010l\u2010carnitine","volume":"18","author":"Hart AM","year":"2004","journal-title":"a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721001-00004"},{"key":"e_1_2_6_18_2","first-page":"1513","article-title":"Epidermal nerve fiber density","volume":"55","author":"McArthur JC","year":"1998","journal-title":"normative reference range and diagnostic efficiency"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02284830"},{"key":"e_1_2_6_20_2","first-page":"1059","article-title":"Assessment of epidermal nerve fibers","volume":"66","author":"Ebenezer GJ","year":"2007","journal-title":"a new diagnostic and predictive tool for peripheral neuropathies"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7216-9491-7.50037-5"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2005.01260.x"},{"issue":"2","key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"M83","DOI":"10.1177\/135965350501002S09","article-title":"Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV\u20101 seropositive and negative individuals","volume":"10","author":"Gerschenson M","year":"2005","journal-title":"Antivir Ther"},{"key":"e_1_2_6_24_2","first-page":"1679","article-title":"HIV neuropathy natural history cohort study","volume":"66","author":"Simpson DM","year":"2006","journal-title":"assessment measures and risk factors"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00467.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00706-005-0333-8"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02094-07"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280701200102"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2008.00658.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2008.00658.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:08:04Z","timestamp":1738894084000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2008.00658.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1468-1293.2008.00658.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00658.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]}}}